Eden Health Acquires Contigo Compounding
August 19, 2025
Eden Health has acquired Contigo Compounding, a licensed 503A compounding pharmacy, to integrate in-house sterile and non-sterile compounding capabilities into its personalized care platform. The acquisition gives Eden direct control of medication preparation and supply chain for faster adjustments, improved adherence, and next-day shipping for members.
- Buyers
- Eden Health
- Targets
- Contigo Compounding
- Industry
- Healthcare Services
- Location
- New Mexico, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Centivo Acquires Eden Health
May 20, 2024
Healthcare Services
Centivo, a primary care-centered health plan, has acquired virtual-first medical provider Eden Health to expand its clinical capabilities and employer reach nationwide. The deal integrates Eden Health’s virtual primary care, mental health, urgent care and proprietary member app into Centivo’s offering and expands Centivo’s market reach to all 50 U.S. states.
-
Elevance Health Acquires Paragon Healthcare
March 11, 2024
Healthcare Services
Elevance Health has closed its acquisition of Plano, Texas–based Paragon Healthcare, an infusion services and drug therapy provider operating more than 40 ambulatory infusion centers and serving over 35,000 patients. Paragon will operate under Elevance’s CarelonRx pharmacy services segment to expand access to specialty medications and scale infusion capabilities; financial terms were not disclosed (Axios reported the purchase may exceed $1 billion).
-
Revelation Pharma (Osceola Capital) Acquires Five Compounding Pharmacies
January 27, 2022
Healthcare Services
Revelation Pharma, a PE-backed specialty pharmacy platform sponsored by Osceola Capital, completed add-on acquisitions of five compounding pharmacies: Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, and Convex Pharmacy. The deals expand Revelation's geographic footprint and clinical capabilities across key U.S. regions and will see some locations merged into existing Revelation businesses (e.g., Wise into Pencol; Convex into Everwell).
-
Fagron Acquires University Compounding Pharmacy (UCP)
January 12, 2026
Pharmaceuticals
Fagron NV has completed the acquisition of University Compounding Pharmacy (UCP), a San Diego–based 503A compounding pharmacy focused on health and wellness, hormones and urology. The transaction has an enterprise value of approximately $41.5 million; UCP had annual revenues of around $25 million and will be integrated to strengthen Fagron's U.S. compounding platform alongside Anazao, with synergies expected over 18–24 months.
-
Vivo Infusion Acquires Specialty Infusion
June 20, 2023
Healthcare Services
Vivo Infusion, a national provider of community-based ambulatory infusion and injection care, has acquired Specialty Infusion, a provider of ambulatory infusion and specialty pharmacy services operating 14 centers across New York, Massachusetts, and New Jersey. The deal expands Vivo's footprint to a combined 55 ambulatory infusion centers across ten states; financial terms were not disclosed.
-
Invictus Pharmacy Acquires Additional Pharmacy Operations to Expand National DTC Platform
January 28, 2026
Healthcare Services
Invictus Pharmacy has completed a strategic acquisition and integration of unnamed additional pharmacy operations, transferring patient records in compliance with federal and state regulations. The deal expands Invictus's nationwide direct-to-consumer and mail-order pharmacy platform, enhancing fulfillment, licensure coverage and technology-enabled patient engagement.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.